Skip to Main Content
06/04/2025|1 minute read

Partner Lee Rosebush presented “Legal Spotlight – FDA’s Removal of Tirzepatide From the Drug Shortage List” at the Compounding Pharmacy Compliance event, June 2-3, 2025, in Boston, Massachusetts. During the presentation, the Outsourcing Facilities Association shared their experiences with the current lawsuit against the FDA regarding moving tirzepatide from the drug shortage list, the present status and expected timeline.

More information.


Featured Insights